the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Opportunities and Challenges for Generic Drugs in Australia

Published by Espicom Business Intelligence Contact us : +1-860-674-8796
Published 2008/03 Content info 74+ PAGES
Product code ES66417
Price From  US $ 940 Order/Price list
US $ 940 Hard Copy
US $ 940 PDF by E-mail (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

FOREWORD

EXECUTIVE SUMMARY

BACKGROUND TO THE MARKET

  • Geography
  • Map of Australia
  • Political Overview
  • Economic Overview
    • Estimated/Projected GDP, 2007-2012
  • Demographics
    • Population
      • Population, June 1995-2006
      • Population by State/Territory, June 2006 (000s)
    • Principal Demographic Indicators
      • Principal Demographic Indicators, 1998-2005
  • The Australian Healthcare System
    • Organisation
      • Commonwealth level
      • State/Territory & Local Governments
    • Healthcare expenditure
      • Total Health Expenditure by Source of Funding, 1998/99 - 2004/05 (A$ millions)
      • Total Health Expenditure by Type, 2001/02 - 2004/05 (A$ millions)
      • Total Health Spending by Type & Source, 2004/05 (A$ millions)
      • Health Expenditure by State/Territory, 1998/99 - 2004/05
    • Hospitals
      • Public/Private Hospitals, 1998/99 - 2004/05
      • Private/Public Hospitals by State/Territory, 2004/05
      • Public/Private Hospital Beds, 1998/99 - 2004/05
      • Public/Private Beds by State/Territory, 2004/05
    • Ambulatory Care
      • Non-Admitted Patient Occasions of Service, Public Acute Hospitals, 1998/99-2004/05
    • Medical personnel
      • Medical Practitioners, 1998-2004
      • Medical Practitioners by State/Territory, 2001-04
      • Medical Specialists, 2002-04

THE AUSTRALIAN GENERIC PHARMACEUTICAL MARKET

  • In Context: the Australian Pharmaceutical Market
    • Summary of the Australian Pharmaceutical Market in 2007
    • Market Projections, 2007-2012
    • Pharmaceutical Expenditure by Source of Funds, 2003/04 - 2005/06 (A$ millions)
    • Percentage Change in Pharmaceutical Expenditure, 1999/00 - 2005/06
  • PBS prescription data
    • PBS Prescriptions, 2001-06 (000s)
    • Government Cost of PBS Prescriptions, 2001-06 (A$ millions)
    • PBS Prescriptions by ATC Category, 2001-06 (000s)
    • Total Cost of PBS Prescriptions by ATC Category, 2001-06 (A$ millions)
    • Top 20 PBS Drugs by Volume, 2004-06
    • Top 20 PBS Drugs by Cost, 2006 (A$ millions)
    • Top 20 Suppliers to the PBS by Value, 2005/06
    • Top 20 Suppliers to the PBS by Volume, 2005/06
    • Top 20 Suppliers to the PBS by Volume, 2005/06
  • Generic Market Size & Projections
    • Projected Generic Market, 2006-2012 (A$ millions)
    • Projected Generic Market, 2006-2012 (US$ millions)
    • Summary Outlook
  • Generics in the PBS Market
    • PBS Data for leading Generic Manufacturers, 2005/06
    • PBS Data for leading Generic Manufacturers, 2005/06 (% of Total)
    • Discounting, Mark-ups and Average Price, 2005/06
    • Discounting, Mark-ups and Average Price, 2005/06
  • Pharmaceutical Regulation
    • International harmonisation
  • Biosimilars in Australia
    • Omnitrope
    • EU regulations adopted, 2006
    • Mayne Pharma
  • Leading Manufacturers & Suppliers
    • Summary of Suppliers to the Australian Generic Market, 2007
    • Alphapharm Pty Limited
    • Financials
      • Alphapharm Sales, 2000-06 (million euros)
      • Alphapharm PBS Data, 2000-06
    • Products
      • Alphapharm Drugs Listed on the PBS, January 2008
    • US presence
      • Alphapharm US FDA ANDA Approvals 2002-07
    • Arrow Pharmaceuticals Pty Ltd
      • Financials
        • Arrow PBS Sales Data, 2005/06
      • Products
        • Arrow Prescription Drug Products (home developed), 2007
        • Arrow Drugs Listed on the PBS, January 2008
    • Aspen Australia
      • Financials
        • Aspen Pharmacare, Australian Sales Results, 2006-07 (million Rand)
      • Products
        • Aspen Prescription Drugs
      • Aspen signs distribution deal with Teva
    • Genepharm Pty Ltd
      • Financials
        • Genepharm Australasia Financial Results, 2006/07 (A$ millions)
      • Products
        • Genepharm Drugs Listed on the PBS, January 2008
      • Supply agreements
    • Generic Health Pty Ltd/Bellwether Pharma
      • Products
        • Bellwether Pharma Drugs Listed on the PBS, January 2008
    • GenRx Pty Ltd
      • GenRx PBS Sales Data, 2005/06
      • Products
        • GenRx Drugs Listed on the PBS, January 2008
    • Mayne Pharma (Hospira)
      • Financials
        • Mayne Financial Results, Fiscal 2005-06
        • Sales by Category, 2006
        • Mayne Pharma PBS Sales, 2003/04 - 2005/06
      • Products
        • Leading Mayne Pharma Products, August 2006
        • Mayne Pharma Drugs Listed on the PBS, January 2008
      • US presence
        • Mayne Pharma ANDA approvals, 2002-07
        • Faulding Pharmaceutical ANDA approvals, 2002-03
    • PharmAust
    • Ranbaxy Australia Pty Limited
      • Products
        • Ranbaxy Australia Drugs Listed on the PBS, January 2008
    • Sandoz Pty Ltd
      • Hexal Australia, PBS Sales 2005/06
      • Products
      • Sandoz Drugs Listed on the PBS, January 2008
    • Sigma Pharmaceuticals (Australia) Pty Ltd
      • Products
        • Sigma Drugs Listed on the PBS, January 2008
      • Orphan Pharmaceuticals
    • Winthrop Pharmaceuticals
      • Products
        • Winthrop Drugs Listed on the PBS, January 2008
  • Pricing & reimbursement: PBS
    • Selected Generic Medicine Price Comparisons, November 2004 (A$)
    • Rise in Co-payment rates, 2005
    • Therapeutic Group Premiums
    • US Free Trade Agreement
    • 12.5% price reductions for new market entrants
    • Government announces further PBS reforms, 2006
  • Intellectual property
    • Data exclusivity
    • ' Springboarding'
    • US Free Trade Agreement, Generic Amendments
      • Evergreening?
    • Ranbaxy fails to overturn patent on Lipitor
  • Pharmaceutical distribution
    • Wholesaling
      • Top Three Wholesalers, Pharmacy Revenues 2006-07 (A$ millions)
    • National Pharmaceutical Services Association
    • Australian Pharmaceutical Industries Ltd (API)
    • Sigma Pharmaceuticals
    • Symbion Health (formerly Mayne Group)
    • Retailing
      • Community Pharmacies by State/Territory, June 2007
      • People per Pharmacy, June 2007
    • New wholesaler/pharmacy margin deal agreed

APPENDIX 1: INTERNATIONAL COMPARISONS

  • Generic Pharmaceutical Expenditure
    • Generic Pharmaceutical Expenditure, 2007 (US$ billions)
    • Generic Pharmaceutical Expenditure per capita, 2007 (US$)
    • Generic Pharmaceutical Expenditure as % of Total, 2007

APPENDIX 2: SOURCES

  • Espicom Sources
  • Australian Government Sources
  • Industry Sources

APPENDIX 3: EXCHANGE RATES

Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.